K. Covens

发表

Interleukin‐15 receptor α expression in inflammatory bowel disease patients before and after normalization of inflammation with infliximab

P. Rutgeerts, S. Vermeire, I. Cleynen, 2013, Immunology.

Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype.

F. Schuit, I. Meyts, X. Bossuyt, 2013, Blood.

Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets

D. Goldblatt, I. Meyts, X. Bossuyt, 2015, Infection and Immunity.

The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide.

A. Vandamme, K. Van Laethem, J. Balzarini, 2010, Antiviral research.

Human CD20+CD43+CD27+CD5- B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae.

I. Meyts, X. Bossuyt, Leen Moens, 2012, The Journal of allergy and clinical immunology.

Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.

A. Vandamme, K. Van Laethem, K. Kabeya, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase

K. Theys, R. Camacho, K. Van Laethem, 2014, Acta clinica Belgica.

Molecular detection of SARS-COV-2 in exhaled breath at the point-of-need

M. Fauvart, R. Labie, Jelle Saldien, 2022, Biosensors and Bioelectronics.

Molecular Detection of SARS-Cov-2 in Exhaled Breath Using a Portable Sampler

M. Fauvart, P. Peumans, R. Labie, 2021 .

Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII

K. Peerlinck, M. Jacquemin, E. Sokal, 2014, Journal of thrombosis and haemostasis : JTH.

The FXR agonist obeticholic acid prevents gut barrier dysfunction and bacterial translocation in cholestatic rats.

T. Roskams, F. Nevens, J. Trebicka, 2015, The American journal of pathology.

Response: Extended analysis of microarray data does not contradict preplasmablast phenotype of human CD20+CD27+CD43+ cells.

X. Bossuyt, M. Jacquemin, B. Verbinnen, 2013, Blood.

Impact on Replicative Fitness of the G48E Substitution in the Protease of HIV-1: An In Vitro and In Silico Evaluation

A. Vandamme, K. Van Laethem, M. de Maeyer, 2008, Journal of acquired immune deficiency syndromes.

A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.

M. Van Ranst, A. Vandamme, K. Van Laethem, 2008, Journal of virological methods.

Use of a piezo-electric microarrayer for site-specific, high throughput contact angle measurements

R. Vos, T. Stakenborg, K. Jans, 2019 .

Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.

K. Van Laethem, J. Balzarini, K. François, 2008, Virology.

HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G.

A. Vandamme, R. Camacho, K. Van Laethem, 2012, The Journal of antimicrobial chemotherapy.

Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs

A. Vandamme, K. Van Laethem, M. Quiñones-Mateu, 2009, Journal of Clinical Microbiology.

Plasma cells are not restricted to the CD27+ phenotype: characterization of CD27-CD43+ antibody-secreting cells

S. Vermeire, M. V. van Zelm, J. V. van Dongen, 2023, Frontiers in immunology.

A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.

M. Van Ranst, A. Vandamme, K. Van Laethem, 2008, Journal of virological methods.